Synthesis and in-vitro anti-EGFR screening of new 1,2,3-triazole-benzimidazole hybrids and insilico studies

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Chiral 1,3,5‐Triazines as Potential EGFR Inhibitors: Pharmacophore Modeling, Synthesis, Molecular Docking, Molecular Dynamics Simulation, and Anticancer Evaluation2025 · 3 citations
2. 2Design, Synthesis, In-Silico Study of Novel Benzofuran Thiazolyl Hydrazones as Anticancer Agents Targeting EGFR Kinase2025
3. 3Indole–1,2,4-triazole hybrids as selective ERK inhibitors: Synthesis, anticancer evaluation, and molecular modeling2025 · 4 citations
4. 4Synthesis, Biological Assessment, and Molecular Docking of New Indoline‐Pyrazine Hybrids as Promising Anticancer Agents2026
5. 5Design, synthesis, anti-breast cancer and in silico studies of substituted triphenyl imidazole- N- alkyl linked indole derivatives2025